Completed PHASE4 INTERVENTIONAL NCT00223561

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

Sponsor: Utrecht Institute for Pharmaceutical Sciences

Conditions ADHD

Interventions methylphenidate

Updated 5 times since 2017 Last updated: Feb 28, 2006 Started: Feb 28, 2003 Completion: Feb 28, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on ADHD, this trial is completed. The trial is conducted by Utrecht Institute for Pharmaceutical Sciences and has accumulated 5 data snapshots since 2003. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Utrecht Institute for Pharmaceutical Sciences

Data source: Utrecht Institute for Pharmaceutical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands